drugset / Trial / NCT06065267

Levofloxacin Concomitant Versus Levofloxacin Sequential

NCT06065267

Phase 4 Not yet recruiting 150 enrolled Damascus Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this trial is to determine the efficacy of levofloxacin based sequential treatment regimen or concomitant levofloxacin based regimens as empirical first-line therapy in the Syrian population

Timeline

Start
2024-01-02
Primary completion
2026-12-31
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 500 unknown
Subject Amoxicillin Other / unclassified 1000 mg
Comparator Esomeprazole Small molecule 20 unknown
Comparator Esomeprazole Small molecule 500 unknown
Comparator Levofloxacin Small molecule 500 mg Oral
Subject Metronidazole Small molecule 500 unknown